GERN shot up over 14% on Friday in heavy trading (4.3 million shares traded versus normal daily average of 727k) after word hit the Street that there would be a stem cell report on 60 Minutes on Sunday night. GERN has a 52 week high of $12.18, and GERN shareholders this weekend are obviously hoping that GERN can eclipse this high if the report is positive on Sunday night.
Sorry, the comment form is closed at this time.